Nanoparticle-mediated gene delivery to tumour neovasculature.

[1]  S. Moghimi,et al.  Therapeutic synthetic polymers: a game of Russian roulette? , 2002, Drug discovery today.

[2]  R. Hynes.  A reevaluation of integrins as regulators of angiogenesis , 2002, Nature Medicine.

[3]  M. Bednarski,et al.  Tumor Regression by Targeted Gene Delivery to the Neovasculature , 2002, Science.

[4]  S M Moghimi,et al.  Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.

[5]  Leaf Huang,et al.  Nonviral vectors in the new millennium: delivery barriers in gene transfer. , 2001, Human gene therapy.

[6]  T. N. Campbell,et al.  Targeted antiangiogenic therapy for cancer using Vitaxin: a humanized monoclonal antibody to the integrin alphavbeta3. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[7]  S. Shreeve,et al.  Heterogeneity of vascular endothelial cells in normal and disease states. , 1998, Pharmacology & therapeutics.

[8]  H. Augustin,et al.  Antiangiogenic tumour therapy: will it work? , 1998, Trends in pharmacological sciences.

[9]  D. Cheresh,et al.  Integrins and cancer. , 1996, Current opinion in cell biology.

[10]  Chandra L. Theesfeld,et al.  Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[11]  D. Hanahan,et al.  Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.

[12]  H. Hammes,et al.  Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor–type integrins inhibits retinal neovascularization , 1996, Nature Medicine.

[13]  D. Cheresh,et al.  Integrin α v β 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels , 1994, Cell.

[14]  D. Cheresh,et al.  Requirement of vascular integrin alpha v beta 3 for angiogenesis. , 1994, Science.

[15]  T. Pawson,et al.  Mutational activation of c-raf-1 and definition of the minimal transforming sequence , 1990, Molecular and cellular biology.

[16]  D. Taverna,et al.  Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins , 2002, Nature Medicine.

[17]  V. Perry,et al.  Antigen markers of macrophage differentiation in murine tissues. , 1992, Current topics in microbiology and immunology.